Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae

被引：136

作者：

Davies, Todd A.

Page, Malcolm G. P.

Shang, Wenchi

Andrew, Ted

Kania, Malgosia

Bush, Karen

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev, LLC, Raritan, NJ 08869 USA

[2] Basilea Pharmaceut AG, CH-4005 Basel, Switzerland

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 07期

关键词：

D O I：

10.1128/AAC.00029-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Ceftobiprole exhibited tight binding to PBP2a in methicillin-resistant Staphylococcus aureus, PBP2x in penicillin-resistant Streptococcus pneumoniae, and PBP3 and other essential penicillin-binding proteins in methicillin-susceptible S. aureus, Escherichia coli, and Pseudomonas aeruginosa. Ceftobiprole also bound well to PBP2 in the latter organisms, contributing to the broad-spectrum antibacterial activity against gram-negative and gram-positive bacteria.

引用

页码：2621 / 2624

页数：4

共 30 条

[1] Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae
Asahi, Y
Ubukata, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2267 - 2273
[2] Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates
Asahi, Y
Takeuchi, Y
Ubukata, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1252 - 1255
[3] Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin
Bogdanovich, T
Ednie, LM
Shapiro, S
Appelbaum, PC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4210 - 4219
[4] Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis
Bogdanovich, Tatiana
Clark, Catherine
Ednie, Lois
Lin, Gengrong
Smith, Kathy
Shapiro, Stuart
Appelbaum, Peter C.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) : 2050 - 2057
[5] Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE
[6] AFFINITIES OF PENICILLINS AND CEPHALOSPORINS FOR THE PENICILLIN-BINDING PROTEINS OF ESCHERICHIA-COLI K-12 AND THEIR ANTIBACTERIAL ACTIVITY
CURTIS, NAC
ORR, D
ROSS, GW
BOULTON, MG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) : 533 - 539
[7] Activities of ceftobiprole and other β-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x
Davies, TA
Shang, WC
Bush, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2530 - 2532
[8] BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis
Entenza, JM
Hohl, P
Heinze-Krauss, I
Glauser, MP
Moreillon, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 171 - 177
[9] Interaction of ceftriaxone with penicillin-binding proteins of Escherichia coli in the presence of human serum albumin
Fontana, R
Aldegheri, M
Ligozzi, M
Lo Cascio, G
Cornaglia, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) : 95 - 98
[10] PENICILLIN-BINDING PROTEINS AND BACTERIAL-RESISTANCE TO BETA-LACTAMS
GEORGOPAPADAKOU, NH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2045 - 2053

← 1 2 3 →